This is an invitation-only meeting of the Institute's Product Liability Forum.
This seminar is organized with the MHRA on the topic of pharmaceutical regulation and medicines licensing. The aim of our seminar is to look in a dispassionate way at broader issues arising from the Seroxat investigation, in particular the inadequacies of the legislative framework & ways in which this can be ameliorated. This will be a rare opportunity to discuss issues relating to the regulation of medicines with the Chief Executive of the MHRA, Professor Kent Woods.
The seminar will run between 17.00 and 19.00, followed by a dinner at the Travellers Club and will cost £85 per person.